Najafi Ramin 4
4 · NovaBay Pharmaceuticals, Inc. · Filed Oct 12, 2012
Insider Transaction Report
Form 4
Najafi Ramin
DirectorChief Executive OfficerOther
Transactions
- Award
Option (right to buy)
2012-10-10+65,000→ 679,852 totalExercise: $1.29From: 2013-10-10Exp: 2022-10-10→ Common Stock (65,000 underlying)
Footnotes (1)
- [F1]Twenty-five percent (25%) of the option shares vest and become exercisable on the first anniversary of the date of grant, and the balance of the option shares vest and become exercisable in a series of twelve (12) equal installments upon the completion of each three (3) months beginning October 10, 2012.